Suppr超能文献

[糖尿病肾病的非经典临床类型与病理改变:综述]

[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review].

作者信息

Fang Chenxi, Sun Liya, Liu Yan, Xiao Li, Sun Lin

机构信息

( 410011) Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1074-1079. doi: 10.12182/20231160102.

Abstract

Diabetic kidney disease (DKD) is a common complication of diabetes mellitus and approximately 1/3 of diabetic patients may progress to DKD. A typical early clinical manifestation of DKD is microalbuminuria and patients may present with macroproteinuria accompanied by a decrease in renal function condition as the disease progresses. It is generally believed that the likelihood of a reversal of the disease is reduced after the development of macroproteinuria in patients with DKD, and that eventually some patients' condition may develop into end-stage renal disease (ESRD). Moreover, the thickening of the glomerular basement membrane, mesangial matrix expansion, Kimmelstiel-Wilson (K-W) nodules, and glomerulosclerosis in end-stage diabetes mellitus are typical pathologic changes of DKD. However, some DKD patients, especially those with type 2 diabetes mellitus (T2DM) combined with DKD, may have diverse clinical manifestations, showing variations in disease progression and regression, and manifesting as non-classical types of DKD, such as normoalbuminuric DKD, proteinuria-reduced DKD, and DKD with rapid decline in renal function. In addition, the formation of crescents, a special pathological change, is observed in renal biopsy. However, this issue is currently under-recognized by clinicians and therefore deserves more attention. In order to improve clinicians' understanding of the presentations and pathological changes of non-classical DKD and the level of DKD prevention and treatment in China, we present a preliminary introduction to the clinical phenotypes and pathological changes of non-classical types of DKD in this paper by summarizing the findings of our prior studies as well as domestic and international literature.

摘要

糖尿病肾病(DKD)是糖尿病常见的并发症,约1/3的糖尿病患者可能进展为DKD。DKD典型的早期临床表现为微量白蛋白尿,随着疾病进展,患者可能出现大量蛋白尿并伴有肾功能下降。一般认为,DKD患者出现大量蛋白尿后疾病逆转的可能性降低,最终部分患者病情可能发展为终末期肾病(ESRD)。此外,终末期糖尿病患者肾小球基底膜增厚、系膜基质扩张、结节性肾小球硬化(K-W结节)和肾小球硬化是DKD的典型病理变化。然而,一些DKD患者,尤其是2型糖尿病(T2DM)合并DKD的患者,可能有多种临床表现,疾病进展和转归存在差异,表现为非经典类型的DKD,如正常白蛋白尿性DKD、蛋白尿减少性DKD和肾功能快速下降的DKD。此外,肾活检中观察到一种特殊的病理变化——新月体形成。然而,目前这一问题尚未得到临床医生的充分认识,因此值得更多关注。为提高我国临床医生对非经典DKD的表现和病理变化的认识以及DKD的防治水平,我们通过总结前期研究及国内外文献的结果,对非经典类型DKD的临床表型和病理变化进行初步介绍。

相似文献

1
[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1074-1079. doi: 10.12182/20231160102.
3
Trajectories of kidney function in diabetes: a clinicopathological update.
Nat Rev Nephrol. 2021 Nov;17(11):740-750. doi: 10.1038/s41581-021-00462-y. Epub 2021 Aug 6.
4
Normoalbuminuric diabetic kidney disease.
Front Med. 2017 Sep;11(3):310-318. doi: 10.1007/s11684-017-0542-7. Epub 2017 Jul 18.
5
Novel biomarkers for prognosticating diabetic kidney disease progression.
Int Urol Nephrol. 2023 Apr;55(4):913-928. doi: 10.1007/s11255-022-03354-7. Epub 2022 Oct 22.
9
The role of Kimmelstiel-Wilson nodule in the kidney outcome in patients with diabetic kidney disease: A two-center retrospective cohort study.
Diabetes Res Clin Pract. 2022 Aug;190:109978. doi: 10.1016/j.diabres.2022.109978. Epub 2022 Jul 7.
10
Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Front Endocrinol (Lausanne). 2022 Jun 3;13:871272. doi: 10.3389/fendo.2022.871272. eCollection 2022.

引用本文的文献

本文引用的文献

1
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.
Front Immunol. 2023 Jul 21;14:1185317. doi: 10.3389/fimmu.2023.1185317. eCollection 2023.
2
Pathophysiology of diabetic kidney disease and autophagy: A review.
Medicine (Baltimore). 2023 Jul 28;102(30):e33965. doi: 10.1097/MD.0000000000033965.
3
Albuminuria and cardiorenal risk.
Curr Opin Cardiol. 2023 Jul 1;38(4):331-336. doi: 10.1097/HCO.0000000000001055. Epub 2023 Mar 28.
5
Targeting inflammation to treat diabetic kidney disease: the road to 2030.
Kidney Int. 2023 Feb;103(2):282-296. doi: 10.1016/j.kint.2022.10.030. Epub 2022 Dec 5.
7
Crescents, an Independent Risk Factor for the Progression of Type 2 Diabetic Kidney Disease.
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2758-2768. doi: 10.1210/clinem/dgac416.
8
Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Front Endocrinol (Lausanne). 2022 Jun 3;13:871272. doi: 10.3389/fendo.2022.871272. eCollection 2022.
9
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.
Diabetes Care. 2022 Jun 2;45(6):1416-1427. doi: 10.2337/dc21-2204.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验